Phenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
More Information Supplier PagePhenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
More Information Supplier PageNSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
More Information Supplier PageNSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
More Information Supplier PageNSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
More Information Supplier PageNSC 131463 is a dihydrofolate reductase potent inhibitor with an IC50 of 1 nM.
More Information Supplier PageNPI-2358 is a synthetic analog of NPI-2350, a natural product isolated from Aspergillus sp., which depolymerizes microtubules in A549 human lung carcinoma cells.
More Information Supplier PageNPI-2358 is a synthetic analog of NPI-2350, a natural product isolated from Aspergillus sp., which depolymerizes microtubules in A549 human lung carcinoma cells.
More Information Supplier PagePhenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
More Information Supplier Page
